Xuanzhu Biopharmaceutical Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2021	FY 2020	2019
Period Ending	Apr '26 Apr 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Market Capitalization	12,431	36,515	-	-	-	-	Upgrade
Enterprise Value	11,706	36,396	-	-	-	-	Upgrade
Last Close Price	24.00	70.50	-	-	-	-	Upgrade
PS Ratio	215.77	633.81	-	-	-	-	Upgrade
PB Ratio	8.15	23.95	-	-	-	-	Upgrade
P/TBV Ratio	10.81	31.77	-	-	-	-	Upgrade
EV/Sales Ratio	203.18	631.74	-	-	-	-	Upgrade
Debt / Equity Ratio	0	0	0.00	0.02	0.02	0	Upgrade
Net Debt / Equity Ratio	-0.48	-0.48	-0.26	-0.39	-0.68	-0.71	Upgrade
Net Debt / EBITDA Ratio	3.42	3.42	0.46	1.37	3.02	4.29	Upgrade
Net Debt / FCF Ratio	-	-	1.92	3.68	2.47	3.62	Upgrade
Asset Turnover	0.04	0.04	0.02	-	-	-	Upgrade
Inventory Turnover	0.26	0.26	0.25	-	-	-	Upgrade
Quick Ratio	3.01	3.01	1.45	3.24	19.95	14.26	Upgrade
Current Ratio	3.75	3.75	2.06	3.79	21.28	14.95	Upgrade
Return on Equity (ROE)	-21.10%	-21.10%	-53.84%	-	-29.47%	-16.87%	Upgrade
Return on Assets (ROA)	-9.60%	-9.60%	-27.97%	-	-15.83%	-14.54%	Upgrade
Return on Capital Employed (ROCE)	-15.40%	-15.40%	-55.40%	-28.80%	-23.00%	-17.70%	Upgrade
Earnings Yield	-2.20%	-0.75%	-	-	-	-	Upgrade
Buyback Yield / Dilution	-3.15%	-3.15%	-	-14.22%	-	-	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.